IRCT20190804044429N5招募中2 期
Efficacy and safety of colchicine on clinical improvement in patients with COVID-19: A randomized, double blind clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Inclusion criteria are adults over the age of 18 with a diagnosis of COVID-19 based on clinical criteria (presence of any symptoms of cough, shortness of breath, fever, and CT scan of the lung for evidence of involvement consistent with COVID-19 infection) or PCR and
- •Had clinical symptoms of COVID-19 within two weeks
排除标准
- •Pregnancy and lactation
- •Severe hepatic insufficiency (Child-pugh C)
- •Renal insufficiency (GFR less than 30 ml/min)
- •Allergy history of colchicine
- •Thrombocytopenia (Platelets less than 100,000 /mm3)
- •Not consent
研究者
相似试验
招募中
2 期
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0IRCT20160920029889N4Mazandaran University of Medical Sciences10
已完成
2 期
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70
招募中
2 期
Efficacy of Colchicine in Treatment of Covid-19Covid 19.Coronavirus as the cause of diseases classified elsewhereB97.2IRCT20201229049872N1Artesh University of Medical Sciences80
已完成
3 期
Evaluation of the effect of Colchicine in the patients with Acute Coroanry SyndromeAcute Coronary Syndrome.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20201117049420N1Shiraz University of Medical Sciences240
招募中
2 期
Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillatioAtrial Fibrillation.Unspecified atrial fibrillationI48.91IRCT20200328046886N6Mazandaran University of Medical Sciences172